U.S. Industrial REITs Stock News

NasdaqGM:MRUS
NasdaqGM:MRUSBiotechs

Merus (MRUS): Reassessing Valuation After a 120% Year-to-Date Rally and Strong Multi-Year Returns

Merus (MRUS) has quietly turned into one of the stronger biotech performers this year, with the stock up more than 120% year to date as investors reprice its antibody pipeline potential. See our latest analysis for Merus. That kind of rerating has not come out of nowhere, with Merus enjoying a powerful 90 day share price return of 42.16% and a standout three year total shareholder return of 597.77%. This suggests momentum is still firmly building around its pipeline story. If Merus has caught...
OTCPK:IRBT.Q
OTCPK:IRBT.QConsumer Durables

iRobot (IRBT): Valuation Check After Chapter 11 Filing and Nasdaq Delisting Decision

iRobot (IRBT) just hit two major turning points at once: a voluntary Chapter 11 filing and a Nasdaq delisting notice, effectively signaling the endgame for its public equity story. See our latest analysis for iRobot. Those Chapter 11 and delisting headlines basically crystallise what the share price had been hinting at for a while. A 1 year total shareholder return of around minus 91 percent and multi year losses show that momentum has not just faded; it has largely evaporated, as equity...
NasdaqGM:RILY
NasdaqGM:RILYCapital Markets

B. Riley Financial (RILY) Q2 Profit From Discontinued Ops Tests Long-Running Bearish Narrative

B. Riley Financial (RILY) has swung back to positive quarterly earnings in Q2 2025, posting revenue of about $199 million and EPS of roughly $2.23, even as trailing 12 month figures still reflect sizable losses. The company has seen revenue move from about $38 million in Q2 2024 to nearly $199 million in Q2 2025, while quarterly EPS has shifted from roughly negative $14.86 to positive $2.23. This sets up a sharp contrast between the latest quarter and its loss making recent history and puts...
NYSE:YEXT
NYSE:YEXTSoftware

Yext (YEXT): Assessing Valuation After a Steady 30% Year-to-Date Share Price Climb

Yext (YEXT) has quietly outperformed many software peers this year, and that kind of steady climb usually means investors see something durable in the story, not just a passing sentiment shift. See our latest analysis for Yext. At a share price of $8.51, Yext’s steady year to date share price return of just over 30 percent and 1 year total shareholder return above 31 percent suggest momentum is still building as investors reassess its growth and profitability profile. If Yext’s climb has you...
NasdaqCM:SNDL
NasdaqCM:SNDLPharmaceuticals

Why SNDL (SNDL) Is Up 12.3% After Renewing Buybacks Amid US Cannabis Rescheduling Hopes

Recently, SNDL Inc. renewed its share repurchase program of up to C$100 million and saw sentiment strengthen after reports that the Trump administration may push to reclassify marijuana to Schedule III in the US, a move that could ease tax and financing constraints across the cannabis industry. Although SNDL remains primarily focused on Canada, shifting expectations around US federal cannabis policy are increasingly influencing how investors view its long-term optionality and capital...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

Discover December 2025's Top Stocks Estimated Below Intrinsic Value

As the U.S. stock market experiences a retreat following delayed jobs data and higher-than-expected unemployment rates, investors are closely monitoring economic indicators and Federal Reserve decisions for future guidance. In such an environment, identifying stocks trading below their intrinsic value can present opportunities for those looking to invest wisely amid market fluctuations.
NYSEAM:CIX
NYSEAM:CIXCommercial Services

US Undiscovered Gems to Watch in December 2025

In the current landscape, major U.S. stock indices like the Dow Jones and S&P 500 have recently retreated, influenced by unexpected unemployment data and shifts in Federal Reserve interest rate policies. Despite these broader market challenges, small-cap stocks often present unique opportunities for investors seeking growth potential in under-the-radar companies. Identifying promising stocks requires an understanding of how these smaller companies can navigate economic fluctuations while...
NasdaqGS:KYTX
NasdaqGS:KYTXBiotechs

Kyverna Therapeutics (KYTX): Reassessing Valuation After Positive KYSA-8 CAR T Data and Planned Equity Raise

Kyverna Therapeutics (KYTX) just delivered positive topline data from its registrational KYSA-8 trial in stiff person syndrome and paired that milestone with a planned $100 million follow on equity raise, a combination the market is watching closely. See our latest analysis for Kyverna Therapeutics. The news has turbocharged sentiment, with Kyverna’s latest share price at $10.82 after a 1 day share price return of 23.23 percent and a year to date share price return of 176.02 percent. This...
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025?

Wondering if OPKO Health at around $1.35 is a bargain hiding in plain sight or a classic value trap? This breakdown will walk you through what the numbers are really saying about the stock. Despite being down 6.9% year to date and 16.1% over the last year, the share price has edged up 5.5% in the last month even as 5-year returns remain a steep 70.4% lower. This mix hints at shifting sentiment rather than a clear trend. Recently, OPKO has stayed on investors' radars as it continues to...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

3 Stocks Estimated To Be Trading At Discounts Of Up To 21.1%

As concerns about an AI bubble continue to weigh on technology stocks, major U.S. indexes have recently closed lower, reflecting investor caution amid looming economic indicators such as the upcoming jobs report. In this climate of uncertainty, identifying undervalued stocks can be a strategic approach for investors looking to capitalize on potential market inefficiencies and secure positions in companies trading at discounts.
OTCPK:MRMD
OTCPK:MRMDPharmaceuticals

Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch

As the U.S. stock market navigates a period of volatility, with major indexes closing lower amid AI bubble concerns and upcoming economic data releases, investors are exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, offer a unique investment avenue that combines affordability with potential growth. Despite being considered an outdated term, these stocks remain relevant by providing access to companies that may have strong financials and growth...